Original InvestigationGlobal Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis
Central Illustration
Key Words
Abbreviations and Acronyms
Cited by (0)
Dr. Mahmood provided cardiovascular event adjudication for PIVOT-2 clinical trials of anticancer therapy; has received a Glorney-Raisbeck Fellowship Award in Cardiovascular Diseases from the New York Academy of Medicine; and has received consultancy fees from Medicure, OMR Globus, Alpha Detail, and Opinion Research Team. Dr. Groarke has received research support from Amgen. Dr. Nohria has received research support from Amgen; and has been a consultant for Takeda Oncology and Triple Gene Therapy. Dr. Heinzerling has received consultancy, advisory board, and speaker fees from Merck Sharp and Dohme, Bristol-Myers Squibb, Roche, Novartis, Amgen, and Curevac; has received research funding from Novartis; and has performed clinical studies for Bristol-Myers Squibb, Merck Sharp & Dohme, Merck, Roche, Amgen, GlaxoSmithKline, Curevac, Iovance, and Novartis. Dr. Cohen has served as a consultant for Sanofi Genzyme and Bristol-Myers Squibb. Dr. Sullivan has served as a consultant to Merck, Novartis, and Bristol-Myers Squibb. Dr. Tocchetti was funded by a “Riceca di Ateneo/Federico II University” grant. Dr. Devereux provided consultation for 1 day in 2018 for Acer Pharmaceuticals about unrelated application to the U.S. Food and Drug Administration for celiprolol for vascular Ehlers-Danlos syndrome. Dr. Lyon has received speaker, advisory board, or consultancy fees and/or research grants from Pfizer, Novartis, Servier, Amgen, Takeda, Roche, Janssens-Cilag Ltd., Clinigen Group, Eli Lily, Eisai, Bristol-Myers Squibb, Ferring Pharmaceuticals, and Boehringer Ingelheim. Dr. Chen’s research was funded in part through the National Institutes of Health/National Cancer Institute Cancer Center Support Grant P30 CA008748. Dr. Barac has received honoraria from Bristol-Myers Squibb; and has served on the Data Safety and Monitoring Board of CTI Biopharma. Dr. Fradley has received research grant support from Medtronic; and has served as a consultant for Novartis. Dr. Neilan has received advisory fees from H3 Biomedicine, Parexel, Aprea Therapeutics, Bristol-Myers Squibb, and Intrinsic Imaging. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.